Image placeholder title

Kisqali Improves Survival in Premenopausal ER+ Advanced Breast Cancer

Kisqali prolongs survival for Pre-menopausal ER positive HER2 Neg breast cancer. San Antonio 2020 update.

Image placeholder title

Herceptin® Improves Cancer-Free Survival in HER2 + positive Early Breast Cancer

Herceptin® should be given for one year for ESBC and can be administered IV or SQ.

Anne Peled

Driving advances in breast cancer surgery

The latest advances in novel surgical techniques which are improving outcomes for breast cancer patients.

Breast Cancer Connect is a unique resource that brings patients, caregivers, advocates and experts together in a single community where individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, treatment, and the support of other individuals being treated at some of the best cancer centers. Breast Cancer Connect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey.